By regulating microtubule-associated tau protein (MAPT) expression, tau splicing, post-translational modifications of tau, and APP expression and processing, as well as inflammation, miRNAs are likely significantly involved in AD pathogenesis and emerge as potential biomarker candidates [120]. This evidence concerns the gene MAPT and Alzheimer disease.